Furthermore, the combination of miR-99b-5p and Enz triggers a synergistic effect to significantly block the recruitment of mTOR and mTOR/AR onto their target genes, potentially serving as a novel therapeutic strategy for treating the resistant CRPC and aggressive AA PCa. The gene discussed is AR; the disease is posterior cortical atrophy.